592 related articles for article (PubMed ID: 26304893)
21. Pediatric Hodgkin Lymphoma.
Mauz-Körholz C; Metzger ML; Kelly KM; Schwartz CL; Castellanos ME; Dieckmann K; Kluge R; Körholz D
J Clin Oncol; 2015 Sep; 33(27):2975-85. PubMed ID: 26304892
[TBL] [Abstract][Full Text] [Related]
22. [Combined therapy for children and adolescents with Ewing tumors (a 25-year experience)].
Yukhta TV; Punanov YA; Kazantsev IV; Malinin AP; Safonova SA; Gafton GI; Gevorgyan AG; Morozova EV; Zubarovskaya LS; Fanasiev BV
Vopr Onkol; 2015; 61(2):233-8. PubMed ID: 26087604
[TBL] [Abstract][Full Text] [Related]
23. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
[TBL] [Abstract][Full Text] [Related]
24. Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management.
Krakorova DA; Kubackova K; Dusek L; Tomas T; Janicek P; Tucek S; Prausova J; Kiss I; Zambo I
Pathol Oncol Res; 2018 Jul; 24(3):623-630. PubMed ID: 28803261
[TBL] [Abstract][Full Text] [Related]
25. Ewing sarcoma: clinical state-of-the-art.
Potratz J; Dirksen U; Jürgens H; Craft A
Pediatr Hematol Oncol; 2012 Feb; 29(1):1-11. PubMed ID: 22295994
[TBL] [Abstract][Full Text] [Related]
26. Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites.
Owosho AA; Ko E; Rosenberg HI; Yom SK; Antonescu CR; Huryn JM; Estilo CL
J Oral Maxillofac Surg; 2016 May; 74(5):973-81. PubMed ID: 26679553
[TBL] [Abstract][Full Text] [Related]
27. Ewing sarcoma: current concepts in diagnosis and treatment.
Kennedy JG; Frelinghuysen P; Hoang BH
Curr Opin Pediatr; 2003 Feb; 15(1):53-7. PubMed ID: 12544272
[No Abstract] [Full Text] [Related]
28. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
[TBL] [Abstract][Full Text] [Related]
29. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
[TBL] [Abstract][Full Text] [Related]
30. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
[TBL] [Abstract][Full Text] [Related]
31. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Paulino AC; Nguyen TX; Mai WY; Teh BS; Wen BC
Pediatr Blood Cancer; 2007 Aug; 49(2):145-8. PubMed ID: 16732580
[TBL] [Abstract][Full Text] [Related]
32. Ewing's sarcoma.
Karosas AO
Am J Health Syst Pharm; 2010 Oct; 67(19):1599-605. PubMed ID: 20852160
[TBL] [Abstract][Full Text] [Related]
33. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
34. Impact of Single Center Treatment on Ewing Sarcoma 10-Year Long Term Survival Rates.
Krieg AH; Gehmert S; Angst R; Rischewski JR; Kühne T; Hefti F
Acta Chir Orthop Traumatol Cech; 2017; 84(6):431-435. PubMed ID: 29351525
[TBL] [Abstract][Full Text] [Related]
35. Ewing's sarcoma.
Balamuth NJ; Womer RB
Lancet Oncol; 2010 Feb; 11(2):184-92. PubMed ID: 20152770
[TBL] [Abstract][Full Text] [Related]
36. Identification of Discrete Prognostic Groups in Ewing Sarcoma.
Karski EE; McIlvaine E; Segal MR; Krailo M; Grier HE; Granowetter L; Womer RB; Meyers PA; Felgenhauer J; Marina N; DuBois SG
Pediatr Blood Cancer; 2016 Jan; 63(1):47-53. PubMed ID: 26257296
[TBL] [Abstract][Full Text] [Related]
37. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
[TBL] [Abstract][Full Text] [Related]
38. Potential approaches to the treatment of Ewing's sarcoma.
Yu H; Ge Y; Guo L; Huang L
Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
[TBL] [Abstract][Full Text] [Related]
39. Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Kuperman AA; Kornreich L; Feinmesser M; Ash S; Yaniv I; Cohen IJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e25-6. PubMed ID: 22935658
[TBL] [Abstract][Full Text] [Related]
40. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
